Leading the Way in Life Science Technologies

GEN Exclusives

More »

Wall Street BioBeat

More »
Apr 1, 2009 (Vol. 29, No. 7)

Staying Ahead of Activist Stockholders

Six Steps Every Public Company Should Be Taking to Maintain Control This Year

  • Tips on How to Maintain Control of Your Company

    • Prepare Immediate Reaction Team
    • Create a small group that plans for and is then capable of responding to activist activity.

    • Monitor Trading Activity
      Watch out daily for share accumulation by activist holders and potential acquirers.

    • Know and Prepare Your Board
      Maintain board unification on key decisions to keep activists from targeting vulnerable directors.

    • Institute Advance Notice Provisions
    • Restrict activists’ opportunity to force board turnover by adding advance notice bylaw.

    • Limit Stockholder Special Meetings
    • Eliminate or make difficult the right of stockholders to call special meetings.

    • Implement Indemnification Rights
    • Avoid potential loss of expense advancement by entering into contractual agreements with directors.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »